| Autor: |
Cassano, N., De Benedittis, M., Petruzzi, M., Carbonara, M., Agnusdei, C., Alessandrini, G., Bellini, M., Callea, A., Carriera, M.L., Coviello, C., Gasparro, E. Crifò, Dattola, S., Ferrari, A., Gabellone, M., Gravante, M., Ligori, P., Liguori, G., Mancino, A., Manco, S., Martina, G., Pietrantonio, V., Postorino, F., Saviozzi, A., Schiraldi, G., Sodo, M.R., Stasi, R., Tortora, G., Zoccali, A., Vena, G.A. |
| Zdroj: |
European Journal of Inflammation; September 2003, Vol. 1 Issue: 3 p125-128, 4p |
| Abstrakt: |
Treatment of cheilitis is usually difficult and often disappointing. We evaluated the effects of a topical preparation containing vitamin E acetate (VEA® lipogel) in 254 patients (mean age, 29.5) with cheilitis of various nature and etiology, involving the vermilion region and/or the perioral skin. The most frequent form of cheilitis was that induced by oral isotretinoin; other forms were irritant contact dermatitis, atopic cheilitis, and contact allergy. Patients were instructed to apply VEA® lipogel daily; the number of daily applications was modulated on the basis of the severity of symptoms (two or three times a day in the majority of cases). After 4 weeks of treatment, clinical examination showed that the severity of symptoms and signs significantly improved (P<0.001). The response to treatment was reported as particularly rapid by 32% of patients. Patient's assessment of overall effectiveness and acceptability was positive in the majority of cases. Treatment was well tolerated; local adverse reactions were observed in 2.75% of patients and were mostly transient and mild. Our experience suggests that VEA® lipogel is an effective and safe approach to cheilitis. The safety of this preparation is also due to the presence of only a few excipients and the absence of fragrances, preservatives and colouring agents. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
